|
Systemic therapy for 12 weeks after primary registration Clinical Trials
1 actively recruiting trial
Pipeline
Phase 3: 1
Top Sponsors
- Tokyo Medical and Dental University1
Indications
- Oligometastasis1
- Metastatic Breast Cancer1
- Breast Cancer1
- Cancer1
Other1 trial
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.